259 related articles for article (PubMed ID: 18181711)
21. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
Saxelin M
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
[TBL] [Abstract][Full Text] [Related]
22. Product development of probiotics as biological drugs.
Sutton A
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S128-32; discussion S144-51. PubMed ID: 18181718
[TBL] [Abstract][Full Text] [Related]
23. Safety assessment of food products from r-DNA animals.
Lema MA; Burachik M
Comp Immunol Microbiol Infect Dis; 2009 Mar; 32(2):163-89. PubMed ID: 18258300
[TBL] [Abstract][Full Text] [Related]
24. [Probiotics--from empirical medicine to therapeutic standard].
Holst H; Breves G
Z Gastroenterol; 2005 Jun; 43(6):601-6. PubMed ID: 15986291
[TBL] [Abstract][Full Text] [Related]
25. Regulating the safety of probiotics--the European approach.
von Wright A
Curr Pharm Des; 2005; 11(1):17-23. PubMed ID: 15638749
[TBL] [Abstract][Full Text] [Related]
26. Probiotics: facts and myths.
Senok AC; Ismaeel AY; Botta GA
Clin Microbiol Infect; 2005 Dec; 11(12):958-66. PubMed ID: 16307549
[TBL] [Abstract][Full Text] [Related]
27. Probiotics for animal nutrition in the European Union. Regulation and safety assessment.
Anadón A; Martínez-Larrañaga MR; Aranzazu Martínez M
Regul Toxicol Pharmacol; 2006 Jun; 45(1):91-5. PubMed ID: 16563585
[TBL] [Abstract][Full Text] [Related]
28. Probiotics: definition, sources, selection, and uses.
Sanders ME
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S58-61; discussion S144-51. PubMed ID: 18181724
[TBL] [Abstract][Full Text] [Related]
29. [Safety of probiotics--a review].
Zhang Z; Liu C; Guo X
Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):257-61. PubMed ID: 18438012
[TBL] [Abstract][Full Text] [Related]
30. Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues.
Sanders ME; Huis in't Veld J
Antonie Van Leeuwenhoek; 1999; 76(1-4):293-315. PubMed ID: 10532385
[TBL] [Abstract][Full Text] [Related]
31. Use of botanicals in food supplements. Regulatory scope, scientific risk assessment and claim substantiation. 2005.
Coppens P; Delmulle L; Gulati O; Richardson D; Ruthsatz M; Sievers H; Sidani S;
Ann Nutr Metab; 2006; 50(6):538-54. PubMed ID: 17191027
[TBL] [Abstract][Full Text] [Related]
32. The impact of international trade agreements on U.S. food safety and labeling standards.
Silverglade BA
Food Drug Law J; 1998; 53(3):537-41. PubMed ID: 10346726
[No Abstract] [Full Text] [Related]
33. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
34. Health claims substantiation for probiotic and prebiotic products.
Sanders ME; Heimbach JT; Pot B; Tancredi DJ; Lenoir-Wijnkoop I; Lähteenmäki-Uutela A; Gueimonde M; Bañares S
Gut Microbes; 2011; 2(3):127-33. PubMed ID: 21646865
[TBL] [Abstract][Full Text] [Related]
35. Safety assessment of commercial Enterococcus probiotics in Korea.
Lee K; Lee M; Lee Y
J Microbiol Biotechnol; 2008 May; 18(5):942-5. PubMed ID: 18633295
[TBL] [Abstract][Full Text] [Related]
36. Environmental assessment requirements for live biological drugs.
Sutton A
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S112-4; discussion S144-51. PubMed ID: 18181713
[TBL] [Abstract][Full Text] [Related]
37. Business considerations in the development of probiotics.
Hoffman FA
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S141-3; discussion S144-51. PubMed ID: 18181721
[TBL] [Abstract][Full Text] [Related]
38. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics.
Sanders ME; Klaenhammer TR; Ouwehand AC; Pot B; Johansen E; Heimbach JT; Marco ML; Tennilä J; Ross RP; Franz C; Pagé N; Pridmore RD; Leyer G; Salminen S; Charbonneau D; Call E; Lenoir-Wijnkoop I
Ann N Y Acad Sci; 2014 Feb; 1309():1-18. PubMed ID: 24571253
[TBL] [Abstract][Full Text] [Related]
39. Mandatory recall authority: a sensible and minimalist approach to improving food safety.
Roberts MT
Food Drug Law J; 2004; 59(4):563-83. PubMed ID: 15875352
[No Abstract] [Full Text] [Related]
40. Probiotics in functional gastrointestinal disorders: what are the facts?
Quigley EM
Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
